Chemo-Pharma [CPL] vs Indo Farm Equipment [INDOFARM] Detailed Stock Comparison
Chemo-Pharma
BSE
Loading...
Indo Farm Equipment
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Chemo-Pharma wins in 8 metrics, Indo Farm Equipment wins in 9 metrics, with 0 ties. Indo Farm Equipment appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Chemo-Pharma | Indo Farm Equipment | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.95 | 44.63 | Chemo-Pharma |
| Price-to-Book Ratio | 2.52 | 1.91 | Indo Farm Equipment |
| Debt-to-Equity Ratio | 44.70 | 32.64 | Indo Farm Equipment |
| PEG Ratio | 0.61 | N/A | N/A |
| EV/EBITDA | 13.68 | 21.08 | Chemo-Pharma |
| Profit Margin (TTM) | 11.11% | 6.49% | Chemo-Pharma |
| Operating Margin (TTM) | 9.62% | 10.57% | Indo Farm Equipment |
| EBITDA Margin (TTM) | 9.62% | 10.57% | Indo Farm Equipment |
| Return on Equity | 20.97% | 4.43% | Chemo-Pharma |
| Return on Assets (TTM) | 11.26% | 3.09% | Chemo-Pharma |
| Free Cash Flow (TTM) | $41.66M | $261.52M | Indo Farm Equipment |
| 1-Year Return | -10.86% | 1.22% | Indo Farm Equipment |
| Price-to-Sales Ratio (TTM) | 1.39 | 2.89 | Chemo-Pharma |
| Enterprise Value | $4.59B | $12.45B | Indo Farm Equipment |
| EV/Revenue Ratio | 1.57 | 3.05 | Chemo-Pharma |
| Gross Profit Margin (TTM) | 29.30% | 43.46% | Indo Farm Equipment |
| Revenue per Share (TTM) | $51 | $94 | Indo Farm Equipment |
| Earnings per Share (Diluted) | $5.66 | $5.51 | Chemo-Pharma |
| Beta (Stock Volatility) | 0.23 | N/A | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Chemo-Pharma vs Indo Farm Equipment Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Chemo-Pharma | -0.63% | 1.22% | -10.60% | -11.27% | -19.24% | -41.64% |
| Indo Farm Equipment | 1.09% | 8.57% | 22.63% | 54.36% | 42.43% | -6.38% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Chemo-Pharma | -10.86% | 284.53% | 120.36% | 729.71% | 1,225.59% | 1,225.59% |
| Indo Farm Equipment | 1.22% | 1.22% | 1.22% | 1.22% | 1.22% | 1.22% |
News Based Sentiment: Chemo-Pharma vs Indo Farm Equipment
Chemo-Pharma
News based Sentiment: NEGATIVE
The significant financial losses reported in Q1 FY26, coupled with underperformance relative to the Sensex, create a concerning picture for investors. While the diversification strategy is a positive development, it doesn't immediately offset the current challenges. The volatile stock price and fluctuating investor participation add to the uncertainty.
Indo Farm Equipment
News based Sentiment: MIXED
The month presented a mixed bag for Indo Farm Equipment. While the company demonstrated impressive profit growth and strategic positioning for future growth, concerns about its high valuation and declining revenue create a complex investment picture. The shifting shareholding patterns also add another layer of consideration for investors.
Performance & Financial Health Analysis: Chemo-Pharma vs Indo Farm Equipment
| Metric | CPL | INDOFARM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.05B | ₹11.84B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 32,878 | 1,050,225 |
| 90 Day Avg. Volume | 33,955 | 882,115 |
| Last Close | ₹67.44 | ₹259.04 |
| 52 Week Range | ₹66.00 - ₹128.00 | ₹136.80 - ₹293.20 |
| % from 52W High | -47.31% | -11.65% |
| All-Time High | ₹128.00 (Jan 06, 2025) | ₹293.20 (Jan 06, 2025) |
| % from All-Time High | -47.31% | -11.65% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.28% |
| Quarterly Earnings Growth | 0.34% | 1.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.06% |
| Operating Margin (TTM) | 0.10% | 0.11% |
| Return on Equity (TTM) | 0.21% | 0.04% |
| Debt to Equity (MRQ) | 44.70 | 32.64 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹26.86 | ₹128.60 |
| Cash per Share (MRQ) | ₹1.01 | ₹23.03 |
| Operating Cash Flow (TTM) | ₹277.99M | ₹485.78M |
| Levered Free Cash Flow (TTM) | ₹313.23M | ₹235.47M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Chemo-Pharma vs Indo Farm Equipment
| Metric | CPL | INDOFARM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.95 | 44.63 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.61 | N/A |
| Price to Sales (TTM) | 1.39 | 2.89 |
| Price to Book (MRQ) | 2.52 | 1.91 |
| Market Capitalization | ||
| Market Capitalization | ₹4.05B | ₹11.84B |
| Enterprise Value | ₹4.59B | ₹12.45B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.57 | 3.05 |
| Enterprise to EBITDA | 13.68 | 21.08 |
| Risk & Other Metrics | ||
| Beta | 0.23 | N/A |
| Book Value per Share (MRQ) | ₹26.86 | ₹128.60 |
Financial Statements Comparison: Chemo-Pharma vs Indo Farm Equipment
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CPL | INDOFARM |
|---|---|---|
| Revenue/Sales | ₹697.42M | ₹962.61M |
| Cost of Goods Sold | ₹493.08M | ₹544.23M |
| Gross Profit | ₹204.34M | ₹418.38M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹67.12M | ₹101.77M |
| EBITDA | ₹79.31M | ₹149.19M |
| Pre-Tax Income | ₹55.13M | ₹75.19M |
| Income Tax | ₹12.13M | ₹20.85M |
| Net Income (Profit) | ₹42.99M | ₹54.34M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CPL | INDOFARM |
|---|---|---|
| Cash & Equivalents | ₹12.05M | ₹71.39M |
| Total Current Assets | ₹2.51B | ₹3.59B |
| Total Current Liabilities | ₹1.17B | ₹2.21B |
| Long-Term Debt | ₹109.50M | ₹714.10M |
| Total Shareholders Equity | ₹1.49B | ₹3.42B |
| Retained Earnings | N/A | ₹2.29B |
| Property, Plant & Equipment | ₹144.04M | ₹0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CPL | INDOFARM |
|---|---|---|
| Operating Cash Flow | N/A | ₹93.91M |
| Capital Expenditures | N/A | ₹-46.08M |
| Free Cash Flow | N/A | ₹20.35M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CPL | INDOFARM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 32,878 | 1,050,225 |
| Average Daily Volume (90 Day) | 33,955 | 882,115 |
| Shares Outstanding | 57.55M | 48.05M |
| Float Shares | 17.06M | 14.17M |
| % Held by Insiders | 0.70% | 0.74% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Chemo-Pharma vs Indo Farm Equipment
| Metric | CPL | INDOFARM |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |